Picture of Kintara Therapeutics logo

KTRA Kintara Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Kintara Therapeutics, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments3.722.3910.511.81.53
Net Total Receivables0.0260.009
Prepaid Expenses
Total Other Current Assets
Total Current Assets4.032.8511.813.33.27
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.150.090.709
Net Intangible Assets
Other Long Term Assets
Total Assets4.042.9413.515.93.98
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities2.072.672.783.993.08
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities2.072.672.964.153.25
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity1.970.26310.611.80.731
Total Liabilities & Shareholders' Equity4.042.9413.515.93.98
Total Common Shares Outstanding
Total Preferred Shares Outstanding